Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2023-02-16 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于收到三亚市市场监督管理局《感谢信》的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding receipt of a thank-you letter from a local market supervision bureau, acknowledging the company's support during a public health situation. It contains no financial data, no regulatory form references, no meeting or voting information, no management changes, no earnings or financial results, and no mention of report attachments. The content is a general corporate announcement about social responsibility and community support. It does not fit into any specific financial report or regulatory filing categories such as Annual Report, Earnings Release, or Management Reports. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2023-02-16 Chinese
关于子公司获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a subsidiary obtaining an invention patent certificate. It includes details about the patent number, name, application date, and validity. There is no financial data, no mention of financial results, no regulatory filings, or meeting materials. The document is a formal announcement about intellectual property, not a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or others related to financial or governance disclosures. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous company announcements that do not fit other specific categories.
2023-02-08 Chinese
关于提前归还非公开发行部分暂时补充流动资金的募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the early repayment of temporarily supplemented funds from non-publicly issued raised funds. It discusses the use and repayment of raised funds, referencing previous board resolutions and announcements. The content focuses on capital management and financing activities, specifically the use and return of raised funds. There are no financial statements or detailed financial results presented, nor is this a report or presentation. The document is a financing update related to capital structure and fund usage. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content support this classification with high confidence.
2023-02-02 Chinese
关于收到广东省新冠感染防控指挥办防控物资保障组《感谢信》的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company acknowledging receipt of a thank-you letter from a government body related to COVID-19 prevention efforts. It contains no financial data, no report or filing of financial results, no management or board changes, no voting results, no capital or financing updates, and no regulatory certifications. The document is essentially a corporate announcement about a non-financial matter (receipt of a letter of appreciation). It is short (998 characters) and does not contain any report or financial statements. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings related to financial or governance matters. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2023-01-29 Chinese
关于收到工业和信息化部《慰问信》的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding receipt of a letter of commendation ('慰问信') from the Ministry of Industry and Information Technology. It describes the company's response to supply challenges during the pandemic and the government's recognition. There is no financial data, no report attached or referenced, no voting results, no management changes, no earnings or capital updates. The document is a regulatory announcement about a government communication, not a financial report or meeting material. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2023-01-19 Chinese
关于提前归还可转债部分暂时补充流动资金的募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the early repayment of part of the funds temporarily used from convertible bond proceeds to supplement working capital. It discusses the use and repayment of raised funds, referencing previous board resolutions and public announcements. The content focuses on capital management and financing activities related to convertible bonds and does not contain financial statements or detailed financial results. The document length is short (954 characters) and is clearly an announcement about capital usage and repayment rather than a full financial report or audit. Therefore, it fits best under Capital/Financing Update (CAP).
2023-01-17 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.